Personalized Intermittent Theta Burst Stimulation for Cognitive Impairment Related to Cerebral Small Vessel Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 160 participants.

Also called NCT07891650

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07891650
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07891650. Randomized; double masking; primary purpose treatment. Start 2026-10 (anticipated); primary completion 2027-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Personalized Intermittent Theta Burst Stimulation for Cognitive Impairment Related to Cerebral Small Vessel Disease
Condition
Cerebral Small Vessel Disease
Condition
Vascular Cognitive Impairment
Intervention (Device)
Active Personalized Intermittent Theta Burst Stimulation
Intervention (Device)
Sham Personalized Intermittent Theta Burst Stimulation
Lead sponsor
Xuanwu Hospital, Beijing (class: other)
Collaborator
Ministry of Science and Technology of the People´s Republic of China (class: other government)
Collaborator
National Natural Science Foundation of China (class: other government)

Record details

Record id
cardio:ct-nct07891650
Content hash
741fd2915d5b5f14e21a23cd45c7e7d2cd882a435034d85f314cfea2ef0e01e6